How to ensure we can track and trace global use of COVID-19 vaccines?

Vander Stichele, Robert H; Hay, Christian; Fladvad, Malin; Sturkenboom, Miriam C J M; Chen, Robert T

Vander Stichele, Robert H; Hay, Christian; Fladvad, Malin; Sturkenboom, Miriam C J M; Chen, Robert T.

Vander Stichele RH; European Institute for Innovation through Health Data, Unicom Project, Belgium; University of Ghent, Gent, Belgium. Electronic address: robert.vanderstichele@ugent.be.
Hay C; GS1Global Office and ISO TC 215, WG 6, Brussels, Belgium.
Fladvad M; Uppsala Monitoring Centre, Uppsala, Sweden.
Sturkenboom MCJM; Julius Global Health, the Netherlands; University Medical Centre Utrecht, Utrecht, the Netherlands.
Chen RT; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA.

Vaccine ; 39(2): 176-179, 2021 01 08.

Article in English | MEDLINE | ID: covidwho-969800

Subject(s)

COVID-19; Viral Vaccines; COVID-19 Vaccines; Humans; Reference Standards; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Vaccine Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google